Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


OxyContin Replacement May Not Solve Abuse

Catasys Health - Tuesday, February 28, 2012

Thousands of Addicts Face Involuntary Withdrawal

By Prithi Yelaja, CBC News
The move to replace the prescription painkiller OxyContin with a newer formulation less prone to misuse won’t solve the crisis of widespread abuse, experts say, unless there is additional training for physicians and treatment for addicts.

Following a similar move in the U.S. in 2010, Purdue Pharma will stop manufacturing OxyContin in Canada and replace it —starting Thursday — with OxyNeo pills, which have been treated to make them extremely difficult to break down.
 » More



CDC director: We can reduce prescription drug overdoses

Catasys Health - Friday, February 24, 2012

By Dr. Frieden
Thirty years ago, I attended medical school in New York. In the key lecture on pain management, the professor told us confidently that patients who received prescription narcotics for pain would not become addicted.

While pain management remains an essential patient right, a generation of health care professionals, patients, and families have learned the hard way how deeply misguided that assertion was. Narcotics - both illegal and legal - are dangerous drugs that can destroy lives and communities.


Millions of Americans struggle with substance abuse. Across the United States, overdoses involving opioid painkillers - a class of drugs with narcotic effects that includes hydrocodone, methadone, oxycodone - have skyrocketed in the past decade.
 » More



Opioids and BPD

Catasys Health - Monday, February 20, 2012

By J.T. Junig, MD, PhD
I appreciate the feedback to my last post.  I had no doubt that the thoughts expressed in the original letter would ring such a chord, as I hear similar comments on a daily basis.  For people new to my blog this week, please review the letter in last week’s post, as that is where I’m starting today.

I had the same ‘love at first site’ reaction to opioids described by many people who become addicted.  My addiction began with a relatively weak opioid — codeine —but I still remember lying in bed as the effects of the substance drifted over me, easing the life-long depression that I had long accepted as ‘just how things are.’
 » More



Opioids Are Rarely the Answer

Catasys Health - Wednesday, February 15, 2012

Doctors need access to education and training programs that are free of industry bias.

By Andrew Kolodny; President of Physicians for Responsible Opioid Prescribing and chairman of the department of psychiatry at Maimonides Medical Center in New York City

Doctors have contributed to an epidemic of overdose deaths and addiction by overprescribing opioids. We didn’t do this out of malicious intent. For most of us, it was a desire to treat pain more compassionately that led to overprescribing. To bring this public health crisis under control, doctors must prescribe more cautiously.

In response to an industry-funded campaign, sales for opioids increased exponentially. Doctors were taught that unrealistic fear of addiction was resulting in needless suffering and that opioids would provide long-term relief of chronic pain. Doctors were misinformed.
 » More



5 Ways to Safeguard Against Opioid Abuse and Diversion From Robert Saenz, CEO of Tulsa Pain Consultants

Catasys Health - Wednesday, January 04, 2012

By Abby Callard
In April 2011, the Office of National Drug Control Policy declared the American opioid abuse problem an epidemic. Robert Saenz, CEO of Tulsa Pain Consultants, president of VIP Medical Consulting and former Federal agent, says physicians need to be more vigilant than ever because they are going to be held more accountable.

"Because of this epidemic, doctors need to be aware that there's a crisis," he says. "The federal government is looking at this, and they're going to hold physicians a lot more accountable than before because there's going to be more resources to do that."
 » More



Mood Disorders Up Risk of Opioid Abuse

Catasys Health - Wednesday, December 14, 2011

By Rick Nauert, PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D.

Mood Disorders Up Risk of Opioid AbuseResearchers have discovered that people suffering from mood and anxiety disorders are more likely to use and abuse non-prescription opioids.

The illnesses associated with abuse of opioids include bipolar disorder, panic disorder and major depression.
Mood disorders in general heighten the risk for substance abuse. In this study,  investigators made a distinction between prescription opioids commonly used for treatment of chronic and acute pain and opioid use that occurs absent a prescription. » More





| 1 2 3 4 | Next

 

 
  Tags
 
opiod abuse addiction treatment UnitedHealthcare muscle relaxant mental health anxiety medical costs buprenorphine facebook ADHD gabapentin fentanyl addiction placebo drinking diabetes drug addiction methamphetamine dependence SD health insurance behavioral health care services primary care drug treatment binge drinking mental illness prescriptions health plan relapse Co Occurring Disorders trauma Opioid Medications opioid antagonist cocaine treatment reduction in use methadone hospitalizations painkillers stratified overdose cocaine SD members oxycodone bipolar disorder urine drug screen percocet smoking Research Across America medical alcohol predictive modeling identification hydrocodone emergency room placebo-controlled relapse prevention narcotic Catasys opiates Raymond Anton opioid-drug interactions withdrawal addict substance dependence health insurance sobriety drug abuse reduction in craving data mining Harold Urschel CIWA dependence issues alcohol treatment sugar recovery contract chronic pain pain medication heroin OnTrak high-utilizing substance dependence ER hospital physician- patient relations substance dependence costs opioid reducing craving naloxone health insurance vicodin ADD social network craving score communication treatment meth flumazenil substance use disorder morphine codeine alcohol drinking behavioral health care care coaching behavioral healthcare services drug use medical and behavioral costs recovery network drug addicts prometa cigarettes alcoholism behavioral health PTSD psychosocial opiod-based pain pills depression screening randomized opioid overdose double-blind vivitrol sober craving over-the-counter substances nicotine post-traumatic stress disorder OxyContin health reform Health Care Utilization alcohol dependence depression methamphetamine stress opioid abuse suboxone marijuana Journal of Psychopharmacology Opioid Treatment behavioral healthcare pain killers stimulants
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025